CANF - Can Fite Biopharma Ltd ADR - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

CANF is currently covered by 2 analysts with an average price target of $7.5. This is a potential upside of $6.06 (420.83%) from yesterday's end of day stock price of $1.44.

Can Fite Biopharma Ltd ADR's activity chart (see below) currently has 30 price targets and 32 ratings on display. The stock rating distribution of CANF is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 38.02% of the time, taking 240 days on average.

Highest price target for CANF is $8, Lowest price target is $7, average price target is $7.5.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 02-Jul-2026. First documented stock forecast 13-Jun-2018.

Best performing analysts who are covering CANF - Can Fite Biopharma Ltd ADR:

Jason Kolbert Vernon Bernardino Swayampakula Ramakanth James Molloy

Currently out of the existing stock ratings of CANF, 4 are a BUY (80%), 1 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 04-Nov-2025

$8

$6.56 (455.56%)

$5

4 months 20 days ago
(02-Jul-2026)

1/3 (33.33%)

$4.09 (104.60%)

302

Hold Since 13-May-2026

$7

$5.56 (386.11%)

6 months 9 days ago
(13-May-2026)

3/16 (18.75%)

$3.36 (92.31%)

388

Buy Since 24-Sep-2019

$18

$18

2 years 10 days ago
(12-Nov-2024)

5/5 (100%)

$-23.6 (-56.73%)

270

Buy Since 15-Jun-2021

$1650

$1800

4 years 11 months 23 days ago
(30-Nov-2021)

0/2 (0%)

$1410 (587.50%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CANF (Can Fite Biopharma Ltd ADR) average time for price targets to be met?

On average it took 240 days for the stock forecasts to be reached, with an average price target met ratio of 38.02%.

Which analyst most recently updated their price target on CANF (Can Fite Biopharma Ltd ADR)?

Swayampakula Ramakanth

Which analyst has the lowest performance score on CANF (Can Fite Biopharma Ltd ADR) with a proven track record?

JIM MOLLOY

Which analyst has the most public recommendations on CANF (Can Fite Biopharma Ltd ADR)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 8 price targets and 14 ratings on CANF

Which analyst is the currently most bullish on CANF (Can Fite Biopharma Ltd ADR)?

James Molloy with the highest potential upside of $1648.56

Which analyst is the currently most reserved on CANF (Can Fite Biopharma Ltd ADR)?

Jason Kolbert with the lowest potential downside of $5.56
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?